InspireMD, Inc. announced on November 8, 2024, that its Compensation Committee approved inducement grants to five new non-executive employees. These grants totaled 197,167 shares of restricted stock, issued outside of InspireMD's 2021 Equity Compensation Plan.
The grants were made as an inducement material to the employees entering into employment with InspireMD, in accordance with Nasdaq Listing Rule 5635(c)(4). The restricted stock vests over a three-year period, with one-third vesting on the first anniversary of the grant and the remainder in two equal installments.
This action reflects InspireMD's ongoing efforts to build its U.S. commercial organization, including marketing, training, and sales operations teams. Attracting new talent is a critical component of the company's preparation for the anticipated U.S. launch of CGuard Prime.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.